Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases
出版年份 2022 全文链接
标题
Adverse drug reactions of Rituximab in patients suffering from autoimmune neurological diseases
作者
关键词
-
出版物
DARU-Journal of Pharmaceutical Sciences
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-09-24
DOI
10.1007/s40199-022-00452-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real‐life study
- (2020) A. Dos Santos et al. EUROPEAN JOURNAL OF NEUROLOGY
- Managing Risks with Immune Therapies in Multiple Sclerosis
- (2019) Moritz Förster et al. DRUG SAFETY
- Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
- (2019) V. Shaygannejad et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis
- (2019) Yang Hu et al. AUTOIMMUNITY REVIEWS
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Evaluating the efficacy and safety of ZytuxTM (Rituximab, AryoGen pharmed) in Iranian multiple sclerosis patients: An observational study
- (2019) Abdorreza Naser Moghadasi et al. Multiple Sclerosis and Related Disorders
- Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
- (2018) Carmen Alcalá et al. JOURNAL OF NEUROLOGY
- Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
- (2018) Barbara Scotti et al. PLoS One
- Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
- (2018) Mathias Granqvist et al. JAMA Neurology
- Incidence of Infectious Disease and Malignancies After Rituximab Therapy in Kidney Transplant Recipients: Results From a Cohort in Germany
- (2017) E. Schrezenmeier et al. TRANSPLANTATION PROCEEDINGS
- Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population
- (2016) Zoran Todorović et al. Patient Preference and Adherence
- Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
- (2016) Valentina Damato et al. JAMA Neurology
- Assessment of a New Instrument for Detecting Preventable Adverse Drug Reactions
- (2014) Raja Benkirane et al. DRUG SAFETY
- Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
- (2014) Ana Luisa Calich et al. JOURNAL OF AUTOIMMUNITY
- Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients
- (2014) Joerg Wendler et al. ARTHRITIS RESEARCH & THERAPY
- Monoclonal antibody therapy-associated neurological disorders
- (2011) Xavier Bosch et al. Nature Reviews Neurology
- Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis
- (2011) F. Conti et al. RHEUMATOLOGY
- Adverse drug reactions to biologics
- (2010) Kathrin Scherer et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
- (2008) Dennis Bourdette et al. Current Neurology and Neuroscience Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started